U.S. Markets closed

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.3700-0.0100 (-0.42%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.3800
Open2.3300
Bid2.3700 x 1000
Ask2.4200 x 800
Day's Range2.3000 - 2.4200
52 Week Range1.7500 - 6.8200
Volume157,801
Avg. Volume201,415
Market Cap49.537M
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)-0.3060
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJun 05, 2015
1y Target EstN/A
  • Benzinga

    35 Stocks Moving In Thursday's Mid-Day Session

    Gainers Gevo, Inc. (NASDAQ: GEVO) shares climbed 36.6% to $7.91. Chevron and Gevo announced intent to pursue sustainable aviation fuel investment. Offerpad Solutions Inc (NYSE: OPAD) surged 35.3% to $15.62. Torrid Holdings Inc. (NYSE: CURV) shares gained 26.1% to $23.29 after the company reported better-than-expected Q2 EPS and sales results. Torrid sees Q3 sales of $305 million - $315 million, above the consensus of $294.74 million. The company expects FY21 sales of $1.29 billion - $1.31 billio

  • GlobeNewswire

    Trinity Biotech Announces Results for Q2, 2021

    DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2021. Quarter 2 ResultsTotal revenues for Q2, 2021 were $25.8m, which compares to $16.0m in Q2, 2020, an increase of $9.8m and which were broken down as follows: 2020Quarter 22021Quarter 2 Increase US$’000US$’000%Point-of-Care1,2671,95854.5%

  • GlobeNewswire

    Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results

    Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERNDUBLIN, Ireland, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2021 on Thursday, September 9, 2021. The Company has scheduled a conference call for that same day, Thursday September 9, 2021 at 11:00am ET (4:00pm BST) to discuss t